Image – Interventional flashlight

DOI: 10.4244/EIJ-D-19-00778

Paradoxical low-flow, low-gradient severe aortic stenosis with mild aortic valve calcification

Xi Li1, MD; Xin Wei1, MD; Hong Tang1, MD; Mao Chen1, PhD

Figure 1. Echocardiography before and after DSE and fluoroscopic images. A) Transthoracic echocardiography suggesting a hypertrophied, small ventricle. B) Continuous wave Doppler echocardiogram showing moderate aortic stenosis (mean pressure gradient 26 mmHg, peak jet velocity 3.2 m/s). C) & D) Echocardiogram showing mild mitral stenosis. E) & F) Computed tomography showing a low calcium burden (calcium volume: 82.4 mm3) with significantly thickened leaflets (G & H). I) Peak jet velocity and mean pressure gradient increased to 4.5 m/s and 43 mmHg, respectively after DSE. DSE: dobutamine stress echocardiography

A 71-year-old male was admitted to our hospital for chest distress and dyspnoea. Transthoracic echocardiography (TTE) revealed concomitant aortic and mitral stenosis with significant thickening of both valves, suggesting rheumatic heart disease. The left ventricle was small and severely hypertrophied (Figure 1A). Haemodynamic measurements (ejection fraction [EF] 69%, stroke volume index 24.17 ml/m2, mean pressure gradient 26 mmHg, peak jet velocity 3.2 m/s, effective valve orifice area 0.7 cm2) (Figure 1B) suggested low-flow, low-gradient aortic stenosis (LFLG-AS) with preserved EF. There was also mild aortic regurgitation and mild mitral stenosis (MS) (Figure 1C, Figure 1D). The patient’s symptoms were mismatched with his AS severity as assessed by the mean gradient, but otherwise unexplainable. Despite the low calcium burden (calcium volume: 82.4 mm3) detected on contrast computed tomography with the threshold set at 850 HU (Figure 1E, Figure 1F), severe AS was considered very likely based on clinical background and imaging data available. Thus, a low-dose dobutamine stress echocardiography (DSE) was performed1 (Figure 1G, Figure 1H), which confirmed severe AS (Figure 1I). The patient ultimately underwent transcatheter aortic valve replacement and experienced profound symptom improvement.

Typically, AS is characterised by calcific degeneration. Therefore, calcium scoring is of critical importance in the assessment of AS severity in the entity of LFLG-AS with preserved EF according to current guidelines2. However, rheumatic AS featuring diffuse fibrosis and commissural fusion is not rare in developing countries. In this paper, we demonstrated an example of “paradoxically” severe LFLG-AS in the presence of only mild valve calcium. The case suggested that the absence of severe valve calcium could not exclude severe AS in the entity of LFLG-AS with preserved EF, where DSE could be helpful. Patients with this entity could suffer from severe AS and require timely interventions.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 15 Number 17
Apr 17, 2020
Volume 15 Number 17
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10SUA8 Sep 27, 2014
Assessment of low-flow, low-gradient aortic stenosis: multimodality imaging is the key to success
Clavel M-A and Pibarot P
free

10.4244/EIJV10I7A134 Nov 20, 2014
Low-flow, low-gradient aortic stenosis: should TAVI be the default therapeutic option?
O’Sullivan C and Wenaweser P
free

10.4244/EIJV9I1A4 May 21, 2013
Indications for and outcomes of valve replacement for asymptomatic aortic valve stenosis
Kunkala M and Schaff H
free

Debate

10.4244/EIJ-E-22-00039 Nov 18, 2022
TAVI in moderate aortic stenosis and heart failure: pros and cons
Delgado V et al
free

Guidelines

10.4244/EIJ-E-21-00009 Feb 4, 2022
2021 ESC/EACTS Guidelines for the management of valvular heart disease
Vahanian A et al
free
Trending articles
318.3

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.85

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
42.95

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved